Overview
- Joint pain and tendon repair
- Skin rejuvenation
- Systemic tissue healing
- Anti-inflammatory baseline
Subcutaneous injection (SubQ)
Drug class: repair blend
80 mg vial + 2 mL BAC → 40 mg/mL
This is the vendor's tested-in-practice recipe for KLOW80. LIA quotes these numbers verbatim; any BAC volume that exceeds the vial capacity or the solubility ceiling is physically impossible and will be rejected.
Clinical Dosing
| Phase | Dose |
|---|---|
| Weeks 1-2 | 2mg total blend |
| Weeks 3-4 | 3mg total blend |
| Week 5+ | 4mg total blend |
Safety Profile
- • Mild injection-site irritation
- • Possible flushing from GHK-Cu copper load
- • Temporary fatigue when ramping
- • Active malignancy (BPC/TB component caution)
- • Wilson's disease (GHK-Cu copper load)
- • Pregnancy / nursing (insufficient data)
Featured in these stacks
Frequently asked questions
Ready to build a protocol with KLOW80?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.